
According to a report by Indonesian newspaper "Jakarta Bulletin" on November 4th, the National Narcotics Agency (BNNP) in Bali, Indonesia is monitoring e-cigarettes to prevent the entry and spread of liquid narcotics on the island.
The Public Relations Coordinator of Bali's BNNP, Made Dwi Saputra, has stated that there is a high demand for e-cigarettes among the general public. Currently, there is rampant drug trafficking, with one method being the use of vape for diluting drugs.
Despite the popularity of e-cigarettes in the community, the National Narcotics Agency (BNNP) aims to prevent the misuse and clandestine distribution of liquid narcotics among e-cigarette users. Brigadier General of Police Raden Nurhadi Yuwono, the head of BNNP, urges e-cigarette manufacturers, suppliers, and consumers to refrain from mixing narcotics in e-liquids and calls on the community to actively report any e-cigarette stores selling narcotics.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.